MiR-204/miR-211 Downregulation Contributes to Candidemia-induced Kidney Injuries Via Derepression of Hmx1 Expression
Overview
Biology
Physiology
Authors
Affiliations
Aims: This study was aimed to exploit the role of heme oxygenase Hmx1 and the potential miRNA mechanisms in the kidney injuries induced by urinary tract infection by Candida species/Candidemia.
Main Methods: We employed a mouse model of systemic Candidiasis by injection of the Candida albicans strain SC5314 into C57BL/6 mice. Kidney injuries were assessed by measuring serum cystatin C (CysC), serum β2-microglobulin (β2-MG) and blood urea nitrogen (BUN). Validation of miRNA target gene was conducted by luciferase reporter gene assay, Western blot analysis and real-time RT-PCR.
Key Findings: We showed here that Candidemia caused significant downregulation of microRNAs miR-204 and miR-211. In sharp contrast, Hmx1 expression was remarkably upregulated, particularly at the protein level. Computational analysis predicted Hmx1 as a target gene for both miR-204 and miR-211 that share the same seed site sequence. We then experimentally validated the targeting relationship between miR-204/miR-211 and Hmx1, which explains the reciprocal changes of expression of miR-204/miR-211 and Hmx1 in Candidemia. Administration of miR-204/miR-211 mimics substantially downregulated Hmx1 and mitigated the severity of the kidney injuries induced by Candidemia, as reflected by improved renal glomerular filtration rate (GFR) determined by serum cystatin C (CysC), serum β2-microglobulin (β2-MG) and blood urea nitrogen (BUN). Knockdown of miR-204/miR-211 worsened while forced expression of miR-204/miR-211 ameliorated kidney injuries in mice with systemic Candidiasis.
Significance: Our findings indicate that miR-204/miR-211 downregulation accounts at least partially for the Hmx1 upregulation and the miR-204/miR-211-Hmx1 signaling axis may contribute to immune-suppression in the host thereby the Candidemia-induced kidney dysfunction.
Haddad G, Blaine J Cells. 2025; 14(5).
PMID: 40072092 PMC: 11899291. DOI: 10.3390/cells14050364.
RNA-Based Therapies in Kidney Diseases.
Hu L, Jin T, Zhang N, Ding J, Li L J Inflamm Res. 2025; 18:3143-3160.
PMID: 40059951 PMC: 11890006. DOI: 10.2147/JIR.S505252.
Gene therapy and kidney diseases.
Tavakolidakhrabadi N, Ding W, Saleem M, Welsh G, May C Mol Ther Methods Clin Dev. 2024; 32(4):101333.
PMID: 39434922 PMC: 11492605. DOI: 10.1016/j.omtm.2024.101333.
Xu C, Yang L, Cheng T, Wang Z, Liu C, Shao J Inflammation. 2024; .
PMID: 38963571 DOI: 10.1007/s10753-024-02091-6.
MicroRNAs as Biomarkers and Therapeutic Targets for Acute Kidney Injury.
Tsuji K, Nakanoh H, Fukushima K, Kitamura S, Wada J Diagnostics (Basel). 2023; 13(18).
PMID: 37761260 PMC: 10529274. DOI: 10.3390/diagnostics13182893.